Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Liposomal protection of adriamycin-induced cardiotoxicity in mice.

× No keyword cloud information.

27 in total

1. Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy.

Authors: D Papahadjopoulos; T M Allen; A Gabizon; E Mayhew; K Matthay; S K Huang; K D Lee; M C Woodle; D D Lasic; C Redemann
Journal: Proc Natl Acad Sci U S A Date: 1991-12-15 Impact factor: 11.205

2. Genotoxicity evaluation of asymmetric lipid polymer hybrid nanoparticles of doxycycline hydrochloride following intravenous administration.

Authors: Maheshkumar P Soni; Madhuvanti V Mahajan; Rohit V Dhumal; Sharad Bhagat; Dinesh Tiwari; Rajiv V Gaikwad; Abdul Samad; Padma V Devarajan; Geeta R Vanage
Journal: Drug Deliv Transl Res Date: 2013-10 Impact factor: 4.617

3. Studies on the myelosuppressive activity of doxorubicin entrapped in liposomes.

Authors: M B Bally; R Nayar; D Masin; P R Cullis; L D Mayer
Journal: Cancer Chemother Pharmacol Date: 1990 Impact factor: 3.333

Review 4. A comparison of liposomal formulations of doxorubicin with drug administered in free form: changing toxicity profiles.

Authors: D N Waterhouse; P G Tardi; L D Mayer; M B Bally
Journal: Drug Saf Date: 2001 Impact factor: 5.606

Review 5. Liposomes in drug delivery. Clinical, diagnostic and ophthalmic potential.

Authors: G Gregoriadis; A T Florence
Journal: Drugs Date: 1993-01 Impact factor: 9.546

6. Liposomes as drug carrier system for cis-diamminedichloroplatinum (II). II. Antitumor activity in vivo, induction of drug resistance, nephrotoxicity and Pt distribution.

Authors: P A Steerenberg; G Storm; G de Groot; A Claessen; J J Bergers; M A Franken; Q G van Hoesel; K L Wubs; W H de Jong
Journal: Cancer Chemother Pharmacol Date: 1988 Impact factor: 3.333

Liposomal protection of adriamycin-induced cardiotoxicity in mice.

1. Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy.

2. Genotoxicity evaluation of asymmetric lipid polymer hybrid nanoparticles of doxycycline hydrochloride following intravenous administration.

3. Studies on the myelosuppressive activity of doxorubicin entrapped in liposomes.

Review 4. A comparison of liposomal formulations of doxorubicin with drug administered in free form: changing toxicity profiles.

Review 5. Liposomes in drug delivery. Clinical, diagnostic and ophthalmic potential.

6. Liposomes as drug carrier system for cis-diamminedichloroplatinum (II). II. Antitumor activity in vivo, induction of drug resistance, nephrotoxicity and Pt distribution.

Review 7. Anthracycline antitumour agents. A review of physicochemical, analytical and stability properties.

Review 8. Liposomes as carriers of cancer chemotherapy. Current status and future prospects.

9. Antitumor and toxicity evaluation of free doxorubicin and doxorubicin entrapped in cardiolipin liposomes.

Review 10. Anthracycline-induced cardiotoxicity and the cardiac-sparing effect of liposomal formulation.